Login / Signup

Development of recalcitrant cutaneous eruptions in patients with relapsed/refractory Hodgkin's lymphoma undergoing treatment with camidanlumab tesirine.

Sonia HimedCatherine ChungBrittany DulmageSamantha JaglowskiDavid BondKami MaddocksBenjamin Harris Kaffenberger
Published in: Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Keyphrases
  • diffuse large b cell lymphoma
  • hodgkin lymphoma
  • acute lymphoblastic leukemia
  • acute myeloid leukemia
  • multiple myeloma
  • combination therapy
  • replacement therapy